McCormick Frank 的 Form 4 申報
BridgeBio Pharma, Inc.（BBIO），2025/10/31 申報
- 申報編號
- 0001470831-25-000282
- 申報時間
- 2025/10/31
- 交易日
- 2025/10/29
- 申報延遲
- 2 天
- 10b5-1 計畫
- 有勾選
這份申報列了 5 筆非衍生性交易。公開市場賣出合計 $1,321 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| McCormick FrankCIK 0001257809 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2025/10/29 | Common Stock | S賣出處分 | −111,755 | $65.48F2 | −$7,317,717.4 | 766,583 | 間接 | |
| 2025/10/29 | Common Stock | S賣出處分 | −31,116 | $66.20F3 | −$2,059,879.2 | 735,467 | 間接 | |
| 2025/10/29 | Common Stock | S賣出處分 | −3,497 | $67.52F4 | −$236,117.44 | 731,970 | 間接 | |
| 2025/10/29 | Common Stock | S賣出處分 | −8,598 | $68.50F5 | −$588,963 | 723,372 | 間接 | |
| 2025/10/29 | Common Stock | S賣出處分 | −43,393 | $69.24F6 | −$3,004,531.32 | 679,979 | 間接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
Represents the weighted average sale price of the shares sold from $65.00 to $65.999 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F3
Represents the weighted average sale price of the shares sold from $66.00 to $66.9875 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F4
Represents the weighted average sale price of the shares sold from $67.00 to $67.996 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F5
Represents the weighted average sale price of the shares sold from $68.005 to $68.99 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F6
Represents the weighted average sale price of the shares sold from $69.00 to $69.24 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。